[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Plasmid DNA CDMO Market Growth (Status and Outlook) 2023-2029

January 2023 | 111 pages | ID: GCD2155ADD8FEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Plasmid DNA CDMO Industry Forecast” looks at past sales and reviews total world Plasmid DNA CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasmid DNA CDMO sales for 2023 through 2029. With Plasmid DNA CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmid DNA CDMO industry.

This Insight Report provides a comprehensive analysis of the global Plasmid DNA CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasmid DNA CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasmid DNA CDMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmid DNA CDMO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmid DNA CDMO.

The global Plasmid DNA CDMO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Plasmid DNA CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Plasmid DNA CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Plasmid DNA CDMO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Plasmid DNA CDMO players cover GenScript ProBio, Biovian, Biomay, VGXI, Esco Aster, Delphi Genetics, Richter-Helm BioLogics, Cytovance Biologics and Cobra Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Plasmid DNA CDMO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • GMP Grade Plasmid DNA
  • Non-GMP Grade Plasmid DNA
Segmentation by application
  • DNA Vaccines
  • Gene Therapy
  • Immunotherapy
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GenScript ProBio
  • Biovian
  • Biomay
  • VGXI
  • Esco Aster
  • Delphi Genetics
  • Richter-Helm BioLogics
  • Cytovance Biologics
  • Cobra Biologics
  • Obiosh
  • Thermo Fisher
  • Aldevron(Danaher)
  • Cognate BioServices (Charles River Laboratories)
  • Pharmaron Inc.
  • Porton
  • WuXi AppTec
  • AGC Biologics
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Plasmid DNA CDMO Market Size 2018-2029
  2.1.2 Plasmid DNA CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Plasmid DNA CDMO Segment by Type
  2.2.1 GMP Grade Plasmid DNA
  2.2.2 Non-GMP Grade Plasmid DNA
2.3 Plasmid DNA CDMO Market Size by Type
  2.3.1 Plasmid DNA CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
2.4 Plasmid DNA CDMO Segment by Application
  2.4.1 DNA Vaccines
  2.4.2 Gene Therapy
  2.4.3 Immunotherapy
  2.4.4 Others
2.5 Plasmid DNA CDMO Market Size by Application
  2.5.1 Plasmid DNA CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)

3 PLASMID DNA CDMO MARKET SIZE BY PLAYER

3.1 Plasmid DNA CDMO Market Size Market Share by Players
  3.1.1 Global Plasmid DNA CDMO Revenue by Players (2018-2023)
  3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid DNA CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PLASMID DNA CDMO BY REGIONS

4.1 Plasmid DNA CDMO Market Size by Regions (2018-2023)
4.2 Americas Plasmid DNA CDMO Market Size Growth (2018-2023)
4.3 APAC Plasmid DNA CDMO Market Size Growth (2018-2023)
4.4 Europe Plasmid DNA CDMO Market Size Growth (2018-2023)
4.5 Middle East & Africa Plasmid DNA CDMO Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Plasmid DNA CDMO Market Size by Country (2018-2023)
5.2 Americas Plasmid DNA CDMO Market Size by Type (2018-2023)
5.3 Americas Plasmid DNA CDMO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Plasmid DNA CDMO Market Size by Region (2018-2023)
6.2 APAC Plasmid DNA CDMO Market Size by Type (2018-2023)
6.3 APAC Plasmid DNA CDMO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Plasmid DNA CDMO by Country (2018-2023)
7.2 Europe Plasmid DNA CDMO Market Size by Type (2018-2023)
7.3 Europe Plasmid DNA CDMO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Plasmid DNA CDMO by Region (2018-2023)
8.2 Middle East & Africa Plasmid DNA CDMO Market Size by Type (2018-2023)
8.3 Middle East & Africa Plasmid DNA CDMO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PLASMID DNA CDMO MARKET FORECAST

10.1 Global Plasmid DNA CDMO Forecast by Regions (2024-2029)
  10.1.1 Global Plasmid DNA CDMO Forecast by Regions (2024-2029)
  10.1.2 Americas Plasmid DNA CDMO Forecast
  10.1.3 APAC Plasmid DNA CDMO Forecast
  10.1.4 Europe Plasmid DNA CDMO Forecast
  10.1.5 Middle East & Africa Plasmid DNA CDMO Forecast
10.2 Americas Plasmid DNA CDMO Forecast by Country (2024-2029)
  10.2.1 United States Plasmid DNA CDMO Market Forecast
  10.2.2 Canada Plasmid DNA CDMO Market Forecast
  10.2.3 Mexico Plasmid DNA CDMO Market Forecast
  10.2.4 Brazil Plasmid DNA CDMO Market Forecast
10.3 APAC Plasmid DNA CDMO Forecast by Region (2024-2029)
  10.3.1 China Plasmid DNA CDMO Market Forecast
  10.3.2 Japan Plasmid DNA CDMO Market Forecast
  10.3.3 Korea Plasmid DNA CDMO Market Forecast
  10.3.4 Southeast Asia Plasmid DNA CDMO Market Forecast
  10.3.5 India Plasmid DNA CDMO Market Forecast
  10.3.6 Australia Plasmid DNA CDMO Market Forecast
10.4 Europe Plasmid DNA CDMO Forecast by Country (2024-2029)
  10.4.1 Germany Plasmid DNA CDMO Market Forecast
  10.4.2 France Plasmid DNA CDMO Market Forecast
  10.4.3 UK Plasmid DNA CDMO Market Forecast
  10.4.4 Italy Plasmid DNA CDMO Market Forecast
  10.4.5 Russia Plasmid DNA CDMO Market Forecast
10.5 Middle East & Africa Plasmid DNA CDMO Forecast by Region (2024-2029)
  10.5.1 Egypt Plasmid DNA CDMO Market Forecast
  10.5.2 South Africa Plasmid DNA CDMO Market Forecast
  10.5.3 Israel Plasmid DNA CDMO Market Forecast
  10.5.4 Turkey Plasmid DNA CDMO Market Forecast
  10.5.5 GCC Countries Plasmid DNA CDMO Market Forecast
10.6 Global Plasmid DNA CDMO Forecast by Type (2024-2029)
10.7 Global Plasmid DNA CDMO Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 GenScript ProBio
  11.1.1 GenScript ProBio Company Information
  11.1.2 GenScript ProBio Plasmid DNA CDMO Product Offered
  11.1.3 GenScript ProBio Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 GenScript ProBio Main Business Overview
  11.1.5 GenScript ProBio Latest Developments
11.2 Biovian
  11.2.1 Biovian Company Information
  11.2.2 Biovian Plasmid DNA CDMO Product Offered
  11.2.3 Biovian Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Biovian Main Business Overview
  11.2.5 Biovian Latest Developments
11.3 Biomay
  11.3.1 Biomay Company Information
  11.3.2 Biomay Plasmid DNA CDMO Product Offered
  11.3.3 Biomay Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Biomay Main Business Overview
  11.3.5 Biomay Latest Developments
11.4 VGXI
  11.4.1 VGXI Company Information
  11.4.2 VGXI Plasmid DNA CDMO Product Offered
  11.4.3 VGXI Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 VGXI Main Business Overview
  11.4.5 VGXI Latest Developments
11.5 Esco Aster
  11.5.1 Esco Aster Company Information
  11.5.2 Esco Aster Plasmid DNA CDMO Product Offered
  11.5.3 Esco Aster Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Esco Aster Main Business Overview
  11.5.5 Esco Aster Latest Developments
11.6 Delphi Genetics
  11.6.1 Delphi Genetics Company Information
  11.6.2 Delphi Genetics Plasmid DNA CDMO Product Offered
  11.6.3 Delphi Genetics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Delphi Genetics Main Business Overview
  11.6.5 Delphi Genetics Latest Developments
11.7 Richter-Helm BioLogics
  11.7.1 Richter-Helm BioLogics Company Information
  11.7.2 Richter-Helm BioLogics Plasmid DNA CDMO Product Offered
  11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Richter-Helm BioLogics Main Business Overview
  11.7.5 Richter-Helm BioLogics Latest Developments
11.8 Cytovance Biologics
  11.8.1 Cytovance Biologics Company Information
  11.8.2 Cytovance Biologics Plasmid DNA CDMO Product Offered
  11.8.3 Cytovance Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Cytovance Biologics Main Business Overview
  11.8.5 Cytovance Biologics Latest Developments
11.9 Cobra Biologics
  11.9.1 Cobra Biologics Company Information
  11.9.2 Cobra Biologics Plasmid DNA CDMO Product Offered
  11.9.3 Cobra Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Cobra Biologics Main Business Overview
  11.9.5 Cobra Biologics Latest Developments
11.10 Obiosh
  11.10.1 Obiosh Company Information
  11.10.2 Obiosh Plasmid DNA CDMO Product Offered
  11.10.3 Obiosh Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Obiosh Main Business Overview
  11.10.5 Obiosh Latest Developments
11.11 Thermo Fisher
  11.11.1 Thermo Fisher Company Information
  11.11.2 Thermo Fisher Plasmid DNA CDMO Product Offered
  11.11.3 Thermo Fisher Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Thermo Fisher Main Business Overview
  11.11.5 Thermo Fisher Latest Developments
11.12 Aldevron(Danaher)
  11.12.1 Aldevron(Danaher) Company Information
  11.12.2 Aldevron(Danaher) Plasmid DNA CDMO Product Offered
  11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 Aldevron(Danaher) Main Business Overview
  11.12.5 Aldevron(Danaher) Latest Developments
11.13 Cognate BioServices (Charles River Laboratories)
  11.13.1 Cognate BioServices (Charles River Laboratories) Company Information
  11.13.2 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product Offered
  11.13.3 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Cognate BioServices (Charles River Laboratories) Main Business Overview
  11.13.5 Cognate BioServices (Charles River Laboratories) Latest Developments
11.14 Pharmaron Inc.
  11.14.1 Pharmaron Inc. Company Information
  11.14.2 Pharmaron Inc. Plasmid DNA CDMO Product Offered
  11.14.3 Pharmaron Inc. Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Pharmaron Inc. Main Business Overview
  11.14.5 Pharmaron Inc. Latest Developments
11.15 Porton
  11.15.1 Porton Company Information
  11.15.2 Porton Plasmid DNA CDMO Product Offered
  11.15.3 Porton Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Porton Main Business Overview
  11.15.5 Porton Latest Developments
11.16 WuXi AppTec
  11.16.1 WuXi AppTec Company Information
  11.16.2 WuXi AppTec Plasmid DNA CDMO Product Offered
  11.16.3 WuXi AppTec Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 WuXi AppTec Main Business Overview
  11.16.5 WuXi AppTec Latest Developments
11.17 AGC Biologics
  11.17.1 AGC Biologics Company Information
  11.17.2 AGC Biologics Plasmid DNA CDMO Product Offered
  11.17.3 AGC Biologics Plasmid DNA CDMO Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 AGC Biologics Main Business Overview
  11.17.5 AGC Biologics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Plasmid DNA CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of GMP Grade Plasmid DNA
Table 3. Major Players of Non-GMP Grade Plasmid DNA
Table 4. Plasmid DNA CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Plasmid DNA CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Table 7. Plasmid DNA CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Plasmid DNA CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Table 10. Global Plasmid DNA CDMO Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Plasmid DNA CDMO Revenue Market Share by Player (2018-2023)
Table 12. Plasmid DNA CDMO Key Players Head office and Products Offered
Table 13. Plasmid DNA CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plasmid DNA CDMO Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Plasmid DNA CDMO Market Size Market Share by Regions (2018-2023)
Table 18. Global Plasmid DNA CDMO Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Plasmid DNA CDMO Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Plasmid DNA CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Plasmid DNA CDMO Market Size Market Share by Country (2018-2023)
Table 22. Americas Plasmid DNA CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Table 24. Americas Plasmid DNA CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Table 26. APAC Plasmid DNA CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Plasmid DNA CDMO Market Size Market Share by Region (2018-2023)
Table 28. APAC Plasmid DNA CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Table 30. APAC Plasmid DNA CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Table 32. Europe Plasmid DNA CDMO Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Plasmid DNA CDMO Market Size Market Share by Country (2018-2023)
Table 34. Europe Plasmid DNA CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Table 36. Europe Plasmid DNA CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Plasmid DNA CDMO Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Plasmid DNA CDMO Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Plasmid DNA CDMO Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Plasmid DNA CDMO
Table 45. Key Market Challenges & Risks of Plasmid DNA CDMO
Table 46. Key Industry Trends of Plasmid DNA CDMO
Table 47. Global Plasmid DNA CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Plasmid DNA CDMO Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Plasmid DNA CDMO Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Plasmid DNA CDMO Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. GenScript ProBio Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 52. GenScript ProBio Plasmid DNA CDMO Product Offered
Table 53. GenScript ProBio Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. GenScript ProBio Main Business
Table 55. GenScript ProBio Latest Developments
Table 56. Biovian Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 57. Biovian Plasmid DNA CDMO Product Offered
Table 58. Biovian Main Business
Table 59. Biovian Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Biovian Latest Developments
Table 61. Biomay Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 62. Biomay Plasmid DNA CDMO Product Offered
Table 63. Biomay Main Business
Table 64. Biomay Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Biomay Latest Developments
Table 66. VGXI Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 67. VGXI Plasmid DNA CDMO Product Offered
Table 68. VGXI Main Business
Table 69. VGXI Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. VGXI Latest Developments
Table 71. Esco Aster Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 72. Esco Aster Plasmid DNA CDMO Product Offered
Table 73. Esco Aster Main Business
Table 74. Esco Aster Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Esco Aster Latest Developments
Table 76. Delphi Genetics Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 77. Delphi Genetics Plasmid DNA CDMO Product Offered
Table 78. Delphi Genetics Main Business
Table 79. Delphi Genetics Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Delphi Genetics Latest Developments
Table 81. Richter-Helm BioLogics Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 82. Richter-Helm BioLogics Plasmid DNA CDMO Product Offered
Table 83. Richter-Helm BioLogics Main Business
Table 84. Richter-Helm BioLogics Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Richter-Helm BioLogics Latest Developments
Table 86. Cytovance Biologics Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 87. Cytovance Biologics Plasmid DNA CDMO Product Offered
Table 88. Cytovance Biologics Main Business
Table 89. Cytovance Biologics Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Cytovance Biologics Latest Developments
Table 91. Cobra Biologics Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 92. Cobra Biologics Plasmid DNA CDMO Product Offered
Table 93. Cobra Biologics Main Business
Table 94. Cobra Biologics Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Cobra Biologics Latest Developments
Table 96. Obiosh Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 97. Obiosh Plasmid DNA CDMO Product Offered
Table 98. Obiosh Main Business
Table 99. Obiosh Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Obiosh Latest Developments
Table 101. Thermo Fisher Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 102. Thermo Fisher Plasmid DNA CDMO Product Offered
Table 103. Thermo Fisher Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Thermo Fisher Main Business
Table 105. Thermo Fisher Latest Developments
Table 106. Aldevron(Danaher) Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 107. Aldevron(Danaher) Plasmid DNA CDMO Product Offered
Table 108. Aldevron(Danaher) Main Business
Table 109. Aldevron(Danaher) Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Aldevron(Danaher) Latest Developments
Table 111. Cognate BioServices (Charles River Laboratories) Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 112. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product Offered
Table 113. Cognate BioServices (Charles River Laboratories) Main Business
Table 114. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Cognate BioServices (Charles River Laboratories) Latest Developments
Table 116. Pharmaron Inc. Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 117. Pharmaron Inc. Plasmid DNA CDMO Product Offered
Table 118. Pharmaron Inc. Main Business
Table 119. Pharmaron Inc. Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Pharmaron Inc. Latest Developments
Table 121. Porton Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 122. Porton Plasmid DNA CDMO Product Offered
Table 123. Porton Main Business
Table 124. Porton Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Porton Latest Developments
Table 126. WuXi AppTec Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 127. WuXi AppTec Plasmid DNA CDMO Product Offered
Table 128. WuXi AppTec Main Business
Table 129. WuXi AppTec Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. WuXi AppTec Latest Developments
Table 131. AGC Biologics Details, Company Type, Plasmid DNA CDMO Area Served and Its Competitors
Table 132. AGC Biologics Plasmid DNA CDMO Product Offered
Table 133. AGC Biologics Main Business
Table 134. AGC Biologics Plasmid DNA CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. AGC Biologics Latest Developments

LIST OF FIGURES

Figure 1. Plasmid DNA CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plasmid DNA CDMO Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Plasmid DNA CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Plasmid DNA CDMO Sales Market Share by Country/Region (2022)
Figure 8. Plasmid DNA CDMO Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Plasmid DNA CDMO Market Size Market Share by Type in 2022
Figure 10. Plasmid DNA CDMO in DNA Vaccines
Figure 11. Global Plasmid DNA CDMO Market: DNA Vaccines (2018-2023) & ($ Millions)
Figure 12. Plasmid DNA CDMO in Gene Therapy
Figure 13. Global Plasmid DNA CDMO Market: Gene Therapy (2018-2023) & ($ Millions)
Figure 14. Plasmid DNA CDMO in Immunotherapy
Figure 15. Global Plasmid DNA CDMO Market: Immunotherapy (2018-2023) & ($ Millions)
Figure 16. Plasmid DNA CDMO in Others
Figure 17. Global Plasmid DNA CDMO Market: Others (2018-2023) & ($ Millions)
Figure 18. Global Plasmid DNA CDMO Market Size Market Share by Application in 2022
Figure 19. Global Plasmid DNA CDMO Revenue Market Share by Player in 2022
Figure 20. Global Plasmid DNA CDMO Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Plasmid DNA CDMO Market Size 2018-2023 ($ Millions)
Figure 22. APAC Plasmid DNA CDMO Market Size 2018-2023 ($ Millions)
Figure 23. Europe Plasmid DNA CDMO Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Plasmid DNA CDMO Market Size 2018-2023 ($ Millions)
Figure 25. Americas Plasmid DNA CDMO Value Market Share by Country in 2022
Figure 26. United States Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Plasmid DNA CDMO Market Size Market Share by Region in 2022
Figure 31. APAC Plasmid DNA CDMO Market Size Market Share by Type in 2022
Figure 32. APAC Plasmid DNA CDMO Market Size Market Share by Application in 2022
Figure 33. China Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Plasmid DNA CDMO Market Size Market Share by Country in 2022
Figure 40. Europe Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Figure 41. Europe Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Figure 42. Germany Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Plasmid DNA CDMO Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Plasmid DNA CDMO Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 56. APAC Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 57. Europe Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 59. United States Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 60. Canada Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 63. China Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 64. Japan Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 65. Korea Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 67. India Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 68. Australia Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 69. Germany Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 70. France Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 71. UK Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 72. Italy Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 73. Russia Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 74. Spain Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 77. Israel Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Plasmid DNA CDMO Market Size 2024-2029 ($ Millions)
Figure 80. Global Plasmid DNA CDMO Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Plasmid DNA CDMO Market Size Market Share Forecast by Application (2024-2029)


More Publications